| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 92.429 | 29.109 | 33.350 | 41.957 | 160.499 | 406.958 | 167.644 | 155.643 | 176.323 |
| Total Income - EUR | - | 92.429 | 29.109 | 33.350 | 41.957 | 160.536 | 413.766 | 199.936 | 156.760 | 185.143 |
| Total Expenses - EUR | - | 7.047 | 10.559 | 48.684 | 34.584 | 144.074 | 310.674 | 188.632 | 137.353 | 160.897 |
| Gross Profit/Loss - EUR | - | 85.382 | 18.550 | -15.335 | 7.373 | 16.462 | 103.092 | 11.304 | 19.406 | 24.247 |
| Net Profit/Loss - EUR | - | 84.444 | 18.258 | -15.668 | 6.953 | 14.949 | 99.075 | 9.325 | 17.839 | 19.744 |
| Employees | - | 2 | 4 | 6 | 3 | 2 | 3 | 4 | 3 | 2 |
Check the financial reports for the company - Star Pharma Trading Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 3.960 | 2.012 | 139 | 27.222 | 29.991 | 21.451 | 10.560 |
| Current Assets | - | 85.221 | 22.412 | 40.739 | 42.066 | 53.519 | 120.894 | 46.126 | 45.099 | 54.661 |
| Inventories | - | 0 | 10.558 | 31.079 | 31.088 | 29.698 | 46.138 | 31.857 | 34.122 | 30.991 |
| Receivables | - | 0 | 6.567 | 9.216 | 9.467 | 11.870 | 14.810 | 6.114 | 6.428 | 23.041 |
| Cash | - | 85.221 | 5.287 | 445 | 1.511 | 11.951 | 59.946 | 8.154 | 4.550 | 629 |
| Shareholders Funds | - | 84.182 | 18.045 | 2.045 | 8.959 | 15.198 | 99.318 | 9.568 | 18.081 | 19.985 |
| Social Capital | - | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 1.039 | 4.368 | 42.655 | 35.119 | 38.460 | 48.797 | 66.622 | 48.594 | 45.237 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Star Pharma Trading Srl